(Q54118860)
Statements
Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. (English)
1 reference
Thakur CP
1 reference
Sinha GP
1 reference
Pandey AK
1 reference
Kumar N
1 reference
Kumar P
1 reference
Hassan SM
1 reference
Narain S
1 reference
Roy RK
1 reference
1 July 1998
1 reference
92
1 reference
5
1 reference
561-569
1 reference
Identifiers
1 reference